The disease process in human hereditary retinal
degenerations is often difficult to analyze, because the time course is
usually slow, and material for morphologic studies is rare. The
availability of transgenic animal models has helped much to obtain
deeper insights in the pathophysiology of these disorders. Humphries et
al.
1 introduced one of these models, the rhodopsin
knockout mouse, in 1997. The Rho
−/− mouse was
primarily used as a model for retinitis pigmentosa (RP), a
heterogeneous group of hereditary disorders of the rod system that
cause progressive retinal degeneration. It is one of the most
frequently seen retinal dystrophies, with an estimated incidence of 1
in 3500 to 1 in 4500 human births. All modes of Mendelian
inheritance—autosomal dominant (ad), autosomal recessive (ar) and
x-linked—have been described. At least two mutations,
Glu249Ter
2 and Glu150Lys,
3 have been reported
to cause arRP due to absence of rhodopsin. RP is characterized by night
blindness, progressive concentric visual field defects leading to
tunnel vision, and a reduced to nondetectable electroretinogram
(ERG).
4 5 6 Ocular findings include pallor of the optic
disc, retinal vessel attenuation, and intraretinal pigment deposits
(bone spicules). Rhodopsin, the visual pigment of the rods, is
necessary to start the phototransduction cascade and also serves as a
structure protein of the discs in the rod outer segments (OSs). Because
homozygous (Rho
−/−) mice carry a replacement
mutation in exon 2 of the rhodopsin gene, they show a complete absence
of rhodopsin and do not build rod outer segments. Similar findings were
reported for knockout mice carrying a different rhodopsin null
mutation.
7 Eventually, this condition leads to progressive
cone degeneration,
8 a common feature known from human RP.
It is not clear whether this degeneration is mostly due to a direct
effect caused by the absence of regular rods, some factors released by
them,
9 or an indirect effect through damage or altered
development of the RPE and/or the choroid.